Impact of sentinel node tumor burden on outcome of invasive breast cancer patients

European Journal of Surgical Oncology

Volumn 40, Issue 10, 2014, Pages 1195-1202

  Meattini, I ^a   Desideri, I ^a   Saieva, C ^b   Francolini, G ^a   Scotti, V ^a   Bonomo, P ^a   Greto, D ^a   Mangoni, M ^a   Nori, J ^a   Orzalesi, L ^a   Fambrini, M ^a   Bianchi, S ^a   Livi, L ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

Author keywords

Invasive breast cancer; Lymphadenectomy; Macrometastases; Micrometastases; Sentinel lymph node; Tumor burden

Indexed keywords

ANTHRACYCLINE; AROMATASE INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; TAMOXIFEN; TRASTUZUMAB; KI 67 ANTIGEN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; IMMUNOHISTOCHEMISTRY; INVASIVE BREAST CANCER; MAJOR CLINICAL STUDY; MICROMETASTASIS; OVERALL SURVIVAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE METASTASIS; TUMOR CELL; TUMOR VOLUME; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; LYMPH NODE; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KI-67 ANTIGEN; LYMPH NODES; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; TUMOR BURDEN;

EID: 84925222880     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2014.08.471     Document Type: Article

References (38)

1. B. Fisher, S. Anderson, and J. Bryant et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
2. U. Veronesi, B. Salvadori, and A. Luini et al. Conservative treatment of early breast cancer: long-term results of 1232 cases treated with quadrantectomy, axillary dissection, and radiotherapy Ann Surg 211 1990 250 259
3. B. Fisher, M. Bauer, and D.L. Wickerham et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update Cancer 52 1983 1551 1557
4. A.E. Giuliano, D.M. Kirgan, and J.M. Guenther et al. Lymphatic mapping and sentinel lymphadenectomy for breast cancer Ann Surg 220 1994 391 398
5. S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, and A. Trotti AJCC cancer staging manual 7th ed. 2010 Springer New York, NY
6. S.L. Chen, F.M. Hoehne, and A.E. Giuliano The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis Ann Surg Oncol 14 2007 3378 3384
7. J. Reed, M. Rosman, and K.M. Verbanac et al. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study J Am Coll Surg 208 2009 333 340
8. M.J. Pepels, M. de Boer, and P. Bult et al. Regional recurrence in breast cancer patients with sentinel node micrometastases and isolated tumor cells Ann Surg 255 2012 116 121
9. S. Milgrom, H. Cody, and L. Tan et al. Characteristics and outcomes of sentinel node-positive breast cancer patients after total mastectomy without axillary-specific treatment Ann Surg Oncol 19 2012 3762 3770
10. A.E. Giuliano, K.K. Hunt, and K.V. Ballman et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial J Am Med Assoc 305 2011 569 575
11. L. Livi, I. Meattini, and D. Franceschini et al. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy Radiother Oncol 108 2013 273 278
12. L. Livi, I. Meattini, and C. Saieva et al. Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer Cancer 118 2012 3236 3243
13. I. Meattini, E. Giannotti, and D. Abdulcadir et al. The impact of method of biopsy on the incidence of breast cancer sentinel lymph node metastases Eur J Surg Oncol 40 2014 277 281
14. I. Meattini, L. Livi, and C. Saieva et al. Prognostic role of human epidermal growth factor receptor 2 status in premenopausal early breast cancer treated with adjuvant tamoxifen Clin Breast Cancer 13 2013 247 253
15. N. Bouzubar, K.J. Walker, and K. Griffiths et al. Ki67 immunostaining in primary breast cancer: pathological and clinical associations Br J Cancer 59 1989 943 947
16. C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer: I. The value of histological grade in breast cancer - experience from a large study with long-term follow-up Histopathology 41 2002 151 152
17. E. Munzone, E. Botteri, and A. Sciandivasci et al. Prognostic value of Ki-67 labeling index in patients with node-negative, triple-negative breast cancer Breast Cancer Res Treat 134 2012 277 282
18. M. Dowsett, T.O. Nielsen, and R. A'Hern et al. Assessment of Ki67 in breast cancer: recommendations from the International Ki67 in Breast Cancer Working Group J Natl Cancer Inst 103 2011 1656 1664
19. C.K. Axelsson, H.T. Mouridsen, and K. Zedeler Axillary dissection of level I and II lymph nodes is important in breast cancer classification Eur J Cancer 28 1992 1415 1418
20. T.F. Hack, L. Cohen, and J. Katz et al. Physical and psychological morbidity after axillary lymph node dissection for breast Cancer J Clin Oncol 17 1999 143 149
21. A. Suyoi, S.K. Bains, and A. Kothari et al. When is a completion axillary lymph node dissection necessary in the presence of a positive sentinel lymph node? Eur J Cancer 50 2014 690 697
22. N.M. Hansen, B. Grube, and X. Ye et al. Impact of micrometastases in the sentinel node of patients with invasive breast cancer J Clin Oncol 27 2009 4679 4684
23. M. de Boer, C.H. van Deurzen, and J.A. van Dijck et al. Micrometastases or isolated tumor cells and the outcome of breast cancer N Engl J Med 361 2009 653 663
24. M. Colleoni, N. Rotmensz, and G. Peruzzotti et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement J Clin Oncol 23 2005 1379 1389
25. A. Goldhirsch, J.N. Ingle, and R.D. Gelber et al. Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 Ann Oncol 20 2009 1319 1329
26. A. Goldhirsch, W.C. Wood, and A.S. Coates et al. Strategies for subtypes - dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 Ann Oncol 22 2011 1736 1747
27. P.D. Gobardhan, S.G. Elias, and E.V. Madsen et al. Prognostic value of micrometastases in sentinel lymph nodes of patients with breast carcinoma: a cohort study Ann Oncol 20 2009 41 48
28. V. Galimberti, B.F. Cole, and S. Zurrida et al. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial Lancet Oncol 14 2013 297 305
29. N.R. Patani, M.V. Dwek, and M. Douek Predictors of axillary lymph node metastasis in breast cancer a systematic review Eur J Surg Oncol 33 2007 409 419
30. G. Viale, S. Zurrida, and E. Maiorano et al. Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution Cancer 103 2005 492 500
31. B. Chua, O. Ung, and R. Taylor et al. Predictors of axillary lymph node metastases in invasive breast cancer ANZ J Surg 71 2001 723 728
32. E. Yoshihara, A. Smeets, and A. Laenen et al. Predictors of axillary lymph node metastases in early breast cancer and their applicability in clinical practice Breast 22 2013 357 361
33. T. Fehm, H. Maul, and S. Gebauer et al. Prediction of axillary lymph node status of breast cancer patients by tumor biological factors of the primary tumor Strahlenther Onkol 181 2005 580 586
34. A. Katz, B.L. Smith, and M. Golshan et al. Nomogram for the prediction of having four or more involved nodes for sentinel lymph node-positive breast cancer J Clin Oncol 26 2008 2093 2098
35. E.A. Mittendorf, K.K. Hunt, and J.C. Boughey et al. Incorporation of sentinel lymph node metastasis size into a nomogram predicting nonsentinel lymph node involvement in breast cancer patients with a positive sentinel lymph node Ann Surg 255 2012 109 115
36. M.E. Straver, P. Meijnen, and G. van Tienhoven et al. Sentinel node identification rate and nodal involvement in the EORTC 10981-22023 AMAROS trial Ann Surg Oncol 17 2010 1854 1861
37. D.N. Krag, S.J. Anderson, and T.B. Julian et al. Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol 11 2010 927 933
38. D.L. Weaver, T. Ashikaga, and D.N. Krag et al. Effect of occult metastases on survival in node-negative breast cancer N Engl J Med 364 2011 412 421